3 Drug Catalysts to Watch in 2013
Motley Fool
Merck Pharmaceuticals' Suvorexant: A Wake-Up Call
Seeking Alpha
Promising insomnia pill from Merck remains 'critical' to future amid recent setbacks
Newark Star-Ledger, NJ
Sleeping Pill Doses Are Cut for Women
Bloomberg
Medical Stocks That Can Make You Sleep
Motley Fool
This Drug Helps Investors Rest Easy
Motley Fool

